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Background: Baroreflex failure syndrome is a rare disorder which causes labile blood pressure, headache, flushing,
diaphoresis and emotional lability. It is caused by history of trauma or radiotherapy in the cervical legion, bilateral
carotid-body tumor or resection of glossopharyngeal nerve. We experienced a case of hemodialysis patient who
had difficulty in controlling blood pressure during dialysis because of his baroreflex failure syndrome and successfully
controlled his blood pressure by adjusting dialysate temperature.
Case presentation: We report a case of a 68-year-old CKD5 patient who had difficulty in hemodialysis treatment
because of severe fluctuations in blood pressure with hypertensive attacks and hypotensive episodes which caused
him a severe discomfort. His dialysis treatment was started in 2010 and since that time baroreflex failure syndrome has
been suspected because of his clinical manifestations and history of radiotherapy in the cervical region for his lingual
cancer in 1994. Baroreflex failure syndrome is diagnosed by symptoms and cold stressor test. We performed a cold
stressor test on an experimental baroreflex failure syndrome mouse and induced a significant elevation of blood
pressure. From this experimental finding of model mouse, we changed the patients dialysate temperature between
34-38° according to his change in blood pressure though 80–240 mmHg. From this attempt, his blood pressure was
successfully controlled between 100–180 mmHg and he was able to continue hemodialysis without any discomfort.
Conclusion: In our case, environmental stimulation such as temperature change modified the patients fluctuating
blood pressure. Change of dialysate temperature could be an option for controlling the unstable blood pressure due
to baroreflex failure syndrome.
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The arterial baroreflex which involves multiple compo-
nents of the baroreflex arc, prevents excessive fluctua-
tions of arterial blood pressure.
The signals by distention of the vessel wall are sent from
baroreceptors in each carotid sinus to the brain stem via
the glossopharyngeal nerve (cranial nerve IX). The infor-
mation from other baroreceptors in the aortic arch and
the great vessels of the thorax are sent through the vagus
nerve (cranial nerve X) to the brain stem. Thoracic blood* Correspondence: h19mstanabe@gmail.com
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unless otherwise stated.volume change detected by low-pressure receptors is also
sent by the vagus nerve to the brain stem.
According to these mentioned mechanism of baroreflex,
any abnormalities in the vascular baroreceptors, the glosso-
pharyngeal or vagus nerves, or the brain stem could cause
baroreflex failure [1].
In clinical setting, baroreflex failure is often caused by
denervation of carotid body tumor resection, carotid ar-
tery surgery, neck irradiation and neck trauma. The fre-
quent symptoms are labile hypertension and hypotension,
often with headache, diaphoresis, face flashing and emo-
tional instability.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pressure which fluctuated through 80 mmHg to 240 mmHg
during dialysis (Figure 1).
Although it was hard to diagnose, we differentiated
our case from autonomic failure, which is common in
chronic hemodialysis patients, by the hyperactive result
to cold pressure stimuli. This is because sympathetic effer-
ents to the vasculature are intact in baroreflex failure and
patients exhibit a normal or even an increased pressor re-
sponse to cold-pressure test [2].
In general, the use of low-temperature dialysate is rec-
ommended to decrease the frequency and intensity of
symptomatic hypotension. From this evidence, we con-
sidered applying this method to stabilize the patients’ la-
bile blood pressure.
This is a case report of baroreflex failure hemodialysis
patient in whom dialysate temperature adjustment was
an effective treatment for labile blood pressure during
hemodialysis caused by baroreflex failure syndrome.
Case presentation
Case
A 68-year-old Danish male presented with multiple epi-
sodes of lightheadedness and the feeling of “passing out”
while he was getting into his bed or when food was ad-
ministered to his gastric fistula tube. And he also had
sudden onset of hypertensive attacks several times a day.
His past medical history was significant for chronic kid-
ney disease and hypertension since he was 30-years-old.
The patient was diagnosed having lingual cancer for
which he received external radiation therapy (RT) at 51-Figure 1 Fluctuating blood pressure during hemodialysis
without changing the dialysate temperature. This is the
hemodynamic change during convectional dialysis before applying
the temperature adjusting dialysis to the patient. The systolic blood
pressure during hemodialysis changed through 80 mmHg to
240 mmHg before we started the dialysate temperature therapy. The
patient suffered from discomfort and diaphoresis from this blood
pressure change.year-old. Ten years after RT, the patient started having
dysphagia and had several episodes of aspiration pneumo-
nia. Modified barium swallow showed he was having silent
aspiration and Percutaneous Endoscopic Gastrostomy
(PEG) was created. Although the patient didn’t have any
oral intake, he still repeated pneumonia and eventually
he underwent tracheotomy. At the same time, his renal
function declined and hemodialysis was started three
times a week. Since then he has been suffering labile blood
pressure.
During dialysis, interdialytic weight increase was con-
trolled between 1.5–1.7 kg (2-3% of body weight) and
ultrafiltration rate was about 6.0 – 6.3 ml/hr/kg. The pa-
tients’ sodium concentration was mostly controlled be-
tween 140 to 142 mEq/L and diffusive sodium balance
during dialysis was negative. Although this stable weight
and sodium control, blood pressure fluctuated through
80 mmHg to 240 mmHg especially during dialysis and
was difficult to control with medications (Figure 1).
His daily blood pressure had been treated by Ca-channel
blocker and ARB but the labile blood pressure could not
be stabilized and he had frequent episodes of fainting and
several occlusion of his arteriovenous fistula (AVF) caused
by extreme hypotension. Everyday, there were several tim-
ings when the blood pressure dropped. Most of the
time it was after inserting food from the PEG and some-
times after lying in bed (Figure 2). His current medication
included Droxidopa and Midodrine Hydrochloride for
hypotensive episodes but his labile blood pressure was dif-
ficult to control with these medications especially during
hemodialyisis.
The dialysate had the following ionic concentration:
140 mEq/L of sodium, 2.0 mEq/L of potassium, 3.0 mEq/LFigure 2 The data of 24 hour ambulatory blood pressure
monitoring (24 hr ABPM). This is the data of 24 hour ABPM on
dialysis day. There was an extreme change in blood pressure during
the day and the patient experienced hypotensive episodes several
times. Most episodes were after inserting meal from PEG and after
lying in bed, when vagus nerve was stimulated. These episodes also
indicate that the patient was unable to have vasovagal reflex when
there was vagus nerve stimulation.
Table 1 The various parameter change during convectional
hemodialysis without temperature adjustment
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ide, and 10 mEq/L of acetate.
Although his blood pressure was extremely unstable,
heart rate was stable and didn’t change more than 10 bpm
during hemodialysis.
Eventually, fifteen years after the neck irradiation, this
patient suffered from edema of his arm with his AVF. It
was caused by the stenosis of his brachial vein and cured
by Percutaneous Transluminal Angioplasty (PTA).
From his current symptom of labile blood pressure with
stable heart rate and medical history of RT and brachial
vein stenosis, we diagnosed him having Baroreflex Failure.
The patient’s labile blood pressure during hemodialysis
was treated with dialysate temperature change. We de-
creased dialysate temperature to 34° when patient’s blood
pressure was low and increased it to 37° when pressure
was getting high. From this trial, his blood pressure was
stabilized between 120–180 mmHg which was ranging
through 80–240 mmHg before the temperature adjust-
ment (Figure 3). Similar to convectional dialysis without
temperature adjustment, the diffusive sodium balance dur-
ing temperature adjusting dialysis was negative and the
ultrafiltration rate was 6.16 ml/hr/kg.
Examination
His physical exam was negative except his hypertension.
Extensive laboratory examinations did not show any ab-
normal findings. Cold pressor test showed 26 mmHg,
15 mmHg increase in sBP, dBP, respectively [2]. During
the day, there were several timings of blood pressure drop,
which was after meals and after lying in bed (Figure 2).
Pathophysiology
At the beginning of every hemodialysis, the patients’ BP
was always higher than normal range with his systolicFigure 3 Less fluctuating blood pressure during hemodialysis
with dialysate temperature therapy. After starting the dialysate
temperature adjustment therapy, blood pressure was less fluctuating
and remained between 120 mmHg to 180 mmHg. This figure shows
the association between the dialysate temperature change and the
blood pressure change.blood pressure around 170 mmHg and it gradually
dropped to around 80 mmHg in the first one hour of
hemodialysis. After reaching the bottom it kept on rising
to 240 mmHg toward the end of the dialysis.
Several factors causing intra-dialysis hemodynamic in-
stability have been reported in many articles in the past.
Inter-dialytic water and sodium control predominantly
affects the intra-dialysis hemodynamic instability [3].
Other than that, sodium concentration change, ultrafiltra-
tion rate, activation of RAA or sympathetic activity during
hemodialysis are the causes of intra-dialysis hemodynamic
instability [4].
In this case, inter-dialytic weight increase was con-
trolled between 1.5–1.7 kg (2-3% of body weight). The
dialysate sodium level was 140 mEq/L and the patients’
pre dialysis plasma sodium level was mostly maintained
between 140 mEq/L to 142 mEq/L. (The dialysis was done
three times a week in the afternoon. The sodium was
measured pre and post dialysis from the site of paracen-
tesis. In order to remove the dialysate affection, sufficient
amount of blood was drawn before the sample taken).
According to the lab results during dialysis, the diffusive
sodium balance during dialysis was negative and the ultra-
filtration rate was 6.30 ml/hr/kg. The transition of lab re-
sults during convectional dialysis without temperature
adjustment is shown below (Table 1).
From these results, the patients hemodynamic instabil-
ity during dialysis was not thought to be caused by vol-
ume overload nor sodium imbalance.
In the process of making the diagnosis, we noticed
that the patients’ heart rate did not change and was
stable compared to his blood pressure instability. FromTime from starting HD (min) 0 60 120 180
sBP (mmHg) 150 109 125 210
dBP (mmHg) 97 74 88 110
HR (bpm) 66 61 65 77
Body Weight change (kg) 73.9 72.3
PRA (ng/ml/hr) 0.3 0.3 0.2 0.3
PAC (pg/ml) 91.6 45.6 52.9 48.4
Adrenaline (pg/ml) 20 32 20 40
Noradrenaline (pg/ml) 158 147 208 227
Dopamine (pg/ml) 38 38 28 26
Hct (%) 34.3 35.8
Na (mEq/L) 140 139
K (mEq/L) 4.1 3.5
Ca (mEq/L) 9.2 10.0
Plasma Osml (mOsm) 305 287
hANP 111 73.8
Figure 4 A fluoroscopic image of the patients occluded brachial vein, pre and post PTA. The patient experienced an occlusion of the
brachial vein 15 years after the neck irradiation. We presume that there was a fibrotic change in the brachial vein from the neck irradiation. We
performed PTA and the fibrotic brachial vein was successfully dilated.
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sure elevation in cold pressor test, we diagnosed him
having baroreflex failure.
The key for diagnosing this case was his medical his-
tory of RT in the cervical region. Among several causes
of baroreflex failure, a history of irradiation around the
cervical region is one of the main reasons [5]. Since the
average duration of time until symptomatic is 5–15
years, it is often seen as a chronic complication in RT.
In particular, after neck irradiation, long-term injury oc-
curs commonly in the carotid arteries. Atherosclerotic
and thrombotic complications occur and cause signifi-
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Figure 5 Cold pressor test on vagotomy model mouse. This figure sho
during cold pressor test. Vagotomy mouse, which is a model of baroreflex
the tail was exposed in 4° water for 2 minutes. This experiment shows that
susceptible to cold stimulation.fact, this patient had medical history of TIA ten years
after the irradiation. Besides atherosclerosis, chronic in-
flammation and fibrosis of carotid arterial walls might
lead to “splinting” of carotid sinus baroreceptors. Since
these receptor are sensitive to stretch or distortion, stiff-
ening of the carotid sinus would be expected to lead to
decreased gain of the arterial baroreflex [6]. In this case,
Right Internal Carotid Artery (R-ICA) starting point
and Left common carotid artery (L-CCA) bifurcation
points Max Intima-media Thickness (IMT) was 3.41 mm
homogenous iso-echoic plaque and 3.68 mm heterogenous
iso-echoic plaque, respectively. While hypo echoic plaque
is usually compatible to hematoma or atheroma, and hyper4
2min
General
1.Adult rat (SD Male 400g)
2.Urethane anesthesia (1.2g/kg)
3.
4.MAP monitor; right femoral artery
 the Cold Pressor Test 
ws the systolic blood pressure change of the vagotomy model mouse
failure, has more increase in blood pressure than normal mouse when
the blood pressure of baroreflex failure model mouse is more
Table 2 The various parameter change during
hemodialysis with temperature adjustment
Time from starting HD (min) 0 60 120 180
sBP (mmHg) 178 132 157 165
dBP (mmHg) 103 77 91 112
HR (bpm) 67 58 59 71
Body Weight change (kg) 74.6 72.9
PRA (ng/ml/hr) 0.6 0.5
PAC (pg/ml) 94.2 44.9
Adrenaline (pg/ml) 17 40
Noradrenaline (pg/ml) 297 144
Dopamine (pg/ml) 88 25
Na (mEq/L) 141 140
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iso-echoic plaque is often seen in case of the fibrosis of
the artery [7].
In addition, three years after starting the temperature
adjustment dialysis, this patient suffered from edema of
his arm which he had his AVF. It was caused by the
stenosis of his brachial vein and cured by Percutaneous
Transluminal Angioplasty (PTA) (Figure 4).
By the facts that Carotid Ultrasonography showed iso-
echoic plaques and he had a brachial vein stenosis which
was cured by PTA, it was compatible to our thought that
the fibrosis of the artery is main reason to cause his
baroreflex failure after radiation therapy.
The recommended medication for baroreflex failure is
antihypertensive and/or vasopressor agents to prevent la-
bile change in blood pressure [5]. Our patient took droxi-
dopa, which was somewhat effective, before meal and lying
in bed because these two situations caused hypotensive
episodes. However the labile blood pressure during
hemodialysis was not able to be stabilized by medications.
The 2005 K/DOQI guidelines [8] recommend the use
of cool dialysate temperature dialysis in patients with
frequent episodes of uncontrolled hypotension during
hemodialysis treatment. Although blood pressure during
dialysis is mostly affected by diffuse sodium balance and
ultrafiltration rate, peripheral temperature stimulation
could change the blood pressure from other pathway.
Since the peripheral nerve is intact in baroreflex failure,
we decided to apply this method to our case. And to re-
veal the temperature susceptibility in baroreflex failure, we
performed a cold pressor experiment on vagotomy model
mouse. From the experiment, vagotomy mouse, which is a
model of baroreflex failure, have more increase in blood
pressure than normal mouse when the tail was exposed
into 4° water for 2 minutes (Figure 5). This suggests the
high susceptibility to temperature change in baroreflex
failure. And in addition to this, our patient used more
dose of droxidopa during summer than during winter.
From these findings, we considered the blood pressure of
baroreflex failure responds more to temperature change
than usual hemodialysis patients.
In our case the diffuse sodium balance was negative and
ultrafiltration rate was 6.30 ml/hr/kg and 6.16 ml/hr/kg in
convectional dialysis (Figure 1) and temperature adjust-
ing dialysis (Figure 3), respectively. This diffuse sodium
balance and ultrafiltration rate was very similar between
the two. Negative diffuse sodium balance may affect the
RAAS pathway and lead to blood pressure change, but
during both dialysis, the Plasma Renin Activity (PRA)
did not change extremely and the Plasma Aldosterone
Concentration (PAC) declined toward the end of the dia-
lysis (Tables 1 and 2). From these results, the previous
hemodynamic instability during dialysis was not likely to
be caused by volume change nor RAAS effect but possiblycased by the overstimulation of autonomic nerve with no
vagal reflex.
From this negative diffuse sodium balance and ultrafiltra-
tion rate similarity between convectional and temperature
adjusting dialysis, we presume that the blood pressure was
successfully controlled through peripheral temperature
stimulation in temperature adjusting dialysis.
From our case, we considered baroreflex failure patient
have more susceptibility to temperature change than usual
hemodialysis patient and temperature adjusting dialysis is
an effective way to control blood pressure in these patients.
Conclusion
Baroreflex failure occurs as a chronic complication for
neck irradiation therapy. Patients who have baroreflex
failure often suffer from their unstable blood pressure.
Baroreflex failure dialysis patient who had an extreme
change in blood pressure during dialysis was treated suc-
cessfully by adjusting the dialysate temperature accord-
ing to the labile blood pressure during hemodialysis.
Consent
Written informed consent was obtained from the patient
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